Another interesting new finding was that m6A modification enhanced the recruitment of miR-133a-RISC (RNA-induced silencing complexes)-AGO2 (Argonaute 2-Insulin-like growth factor 2) to its targets in heart development and in response to cardiac hypertrophy and proliferation [51]. The gene discussed is IGF2; the disease is cardiac hypertrophy.